JP3298400007
JP3298400007
COSMOS PHARMACEUTICAL CORP
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2026 | 2025 | Change % |
|---|---|---|---|
| Total Revenue | 1.099.583.000.000 | 1.011.390.000.000 | 8.7% |
| Cost of Revenue | 869.900.000.000 | 798.109.000.000 | 9.0% |
| Gross Profit | 229.683.000.000 | 213.281.000.000 | 7.7% |
| 187.330.000.000 | 172.877.000.000 | 8.4% | |
| Operating Income | 42.353.000.000 | 40.404.000.000 | 4.8% |
| Pretax Income | 44.218.000.000 | 42.372.000.000 | 4.4% |
| Net Income Common Stockholders | 32.046.000.000 | 30.978.000.000 | 3.4% |
| -- | -- | -- | |
| -- | -- | -- |